Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression.

Bendall ML, de Mulder M, Iñiguez LP, Lecanda-Sánchez A, Pérez-Losada M, Ostrowski MA, Jones RB, Mulder LCF, Reyes-Terán G, Crandall KA, Ormsby CE, Nixon DF.

PLoS Comput Biol. 2019 Sep 30;15(9):e1006453. doi: 10.1371/journal.pcbi.1006453. eCollection 2019 Sep.

2.

IL-15 regulates susceptibility of CD4+ T cells to HIV infection.

Manganaro L, Hong P, Hernandez MM, Argyle D, Mulder LCF, Potla U, Diaz-Griffero F, Lee B, Fernandez-Sesma A, Simon V.

Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9659-E9667. doi: 10.1073/pnas.1806695115. Epub 2018 Sep 26.

3.

HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.

Young GR, Terry SN, Manganaro L, Cuesta-Dominguez A, Deikus G, Bernal-Rubio D, Campisi L, Fernandez-Sesma A, Sebra R, Simon V, Mulder LCF.

J Virol. 2017 Dec 14;92(1). pii: e01507-17. doi: 10.1128/JVI.01507-17. Print 2018 Jan 1.

4.

Expression of HERV-K108 envelope interferes with HIV-1 production.

Terry SN, Manganaro L, Cuesta-Dominguez A, Brinzevich D, Simon V, Mulder LCF.

Virology. 2017 Sep;509:52-59. doi: 10.1016/j.virol.2017.06.004. Epub 2017 Jun 9.

5.

Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection.

Aguirre S, Luthra P, Sanchez-Aparicio MT, Maestre AM, Patel J, Lamothe F, Fredericks AC, Tripathi S, Zhu T, Pintado-Silva J, Webb LG, Bernal-Rubio D, Solovyov A, Greenbaum B, Simon V, Basler CF, Mulder LC, García-Sastre A, Fernandez-Sesma A.

Nat Microbiol. 2017 Mar 27;2:17037. doi: 10.1038/nmicrobiol.2017.37.

PMID:
28346446
6.

Comparative Analysis of HIV-1 and Murine Leukemia Virus Three-Dimensional Nuclear Distributions.

Quercioli V, Di Primio C, Casini A, Mulder LCF, Vranckx LS, Borrenberghs D, Gijsbers R, Debyser Z, Cereseto A.

J Virol. 2016 Apr 29;90(10):5205-5209. doi: 10.1128/JVI.03188-15. Print 2016 May 15.

7.

Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.

Heaton NS, Moshkina N, Fenouil R, Gardner TJ, Aguirre S, Shah PS, Zhao N, Manganaro L, Hultquist JF, Noel J, Sachs D, Hamilton J, Leon PE, Chawdury A, Tripathi S, Melegari C, Campisi L, Hai R, Metreveli G, Gamarnik AV, García-Sastre A, Greenbaum B, Simon V, Fernandez-Sesma A, Krogan NJ, Mulder LCF, van Bakel H, Tortorella D, Taunton J, Palese P, Marazzi I.

Immunity. 2016 Jan 19;44(1):46-58. doi: 10.1016/j.immuni.2015.12.017. Erratum in: Immunity. 2016 Feb 16;44(2):438. Sachs, David H [corrected to Sachs, David].

8.

Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.

Tripathi S, Pohl MO, Zhou Y, Rodriguez-Frandsen A, Wang G, Stein DA, Moulton HM, DeJesus P, Che J, Mulder LC, Yángüez E, Andenmatten D, Pache L, Manicassamy B, Albrecht RA, Gonzalez MG, Nguyen Q, Brass A, Elledge S, White M, Shapira S, Hacohen N, Karlas A, Meyer TF, Shales M, Gatorano A, Johnson JR, Jang G, Johnson T, Verschueren E, Sanders D, Krogan N, Shaw M, König R, Stertz S, García-Sastre A, Chanda SK.

Cell Host Microbe. 2015 Dec 9;18(6):723-35. doi: 10.1016/j.chom.2015.11.002.

9.

Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.

Yen B, Mulder LC, Martinez O, Basler CF.

J Virol. 2014 Nov;88(21):12500-10. doi: 10.1128/JVI.02163-14. Epub 2014 Aug 20.

10.

HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.

Brinzevich D, Young GR, Sebra R, Ayllon J, Maio SM, Deikus G, Chen BK, Fernandez-Sesma A, Simon V, Mulder LC.

J Virol. 2014 Jun;88(11):6213-23. doi: 10.1128/JVI.00669-14. Epub 2014 Mar 19.

11.

Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-γ.

Opaluch AM, Schneider M, Chiang CY, Nguyen QT, Maestre AM, Mulder LC, Secundino I, De Jesus PD, König R, Simon V, Nizet V, MacLeod G, Varmuza S, Fernandez-Sesma A, Chanda SK.

PLoS One. 2014 Feb 20;9(2):e89284. doi: 10.1371/journal.pone.0089284. eCollection 2014.

12.

Balancing selection on a regulatory region exhibiting ancient variation that predates human-neandertal divergence.

Gokcumen O, Zhu Q, Mulder LC, Iskow RC, Austermann C, Scharer CD, Raj T, Boss JM, Sunyaev S, Price A, Stranger B, Simon V, Lee C.

PLoS Genet. 2013 Apr;9(4):e1003404. doi: 10.1371/journal.pgen.1003404. Epub 2013 Apr 11.

13.

Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.

Morrison J, Laurent-Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, Simon V, Mulder LC, Fernandez-Sesma A, García-Sastre A.

PLoS Pathog. 2013 Mar;9(3):e1003265. doi: 10.1371/journal.ppat.1003265. Epub 2013 Mar 28.

14.

DENV inhibits type I IFN production in infected cells by cleaving human STING.

Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A.

PLoS Pathog. 2012;8(10):e1002934. doi: 10.1371/journal.ppat.1002934. Epub 2012 Oct 4.

15.

SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.

Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, Esly N, Panitz S, Reuter A, Ramos I, Jatiani A, Mulder LC, Fernandez-Sesma A, Rutsch F, Simon V, König R, Flory E.

PLoS Pathog. 2011 Dec;7(12):e1002425. doi: 10.1371/journal.ppat.1002425. Epub 2011 Dec 8.

16.

Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.

Mulder LC, Ooms M, Majdak S, Smedresman J, Linscheid C, Harari A, Kunz A, Simon V.

J Virol. 2010 Sep;84(18):9613-7. doi: 10.1128/JVI.02630-09. Epub 2010 Jun 30.

17.

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.

Harari A, Ooms M, Mulder LC, Simon V.

J Virol. 2009 Jan;83(1):295-303. doi: 10.1128/JVI.01665-08. Epub 2008 Oct 22.

18.

Cytidine deamination induced HIV-1 drug resistance.

Mulder LC, Harari A, Simon V.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5501-6. doi: 10.1073/pnas.0710190105. Epub 2008 Apr 7.

19.

Characterization of HIV-1 integrase N-terminal mutant viruses.

Lloyd AG, Ng YS, Muesing MA, Simon V, Mulder LC.

Virology. 2007 Mar 30;360(1):129-35. Epub 2006 Nov 14.

20.

Effect of DNA repair protein Rad18 on viral infection.

Lloyd AG, Tateishi S, Bieniasz PD, Muesing MA, Yamaizumi M, Mulder LC.

PLoS Pathog. 2006 May;2(5):e40. Epub 2006 May 19.

21.

A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.

Tasaki T, Mulder LC, Iwamatsu A, Lee MJ, Davydov IV, Varshavsky A, Muesing M, Kwon YT.

Mol Cell Biol. 2005 Aug;25(16):7120-36.

22.

Interaction of HIV-1 integrase with DNA repair protein hRad18.

Mulder LC, Chakrabarti LA, Muesing MA.

J Biol Chem. 2002 Jul 26;277(30):27489-93. Epub 2002 May 16.

23.

Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes.

Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K, Cintorino M, Bensi G, Rossini M, Mora M.

Oncogene. 2001 Dec 6;20(56):8148-53.

24.

An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.

Mora M, Lazzer M, Marsicano G, Mulder LC, Carraresi L, Pieri A, Benanchi A, Grifoni D, Nuti S, Bruzzone P, Comporti M, Cortesini R, Rossini M.

Transgenic Res. 2000 Jun;9(3):205-13.

PMID:
11032369
25.

Degradation of HIV-1 integrase by the N-end rule pathway.

Mulder LC, Muesing MA.

J Biol Chem. 2000 Sep 22;275(38):29749-53.

26.

CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.

Mariani R, Wong S, Mulder LC, Wilkinson DA, Reinhart AL, LaRosa G, Nibbs R, O'Brien TR, Michael NL, Connor RI, Macdonald M, Busch M, Koup RA, Landau NR.

J Virol. 1999 Mar;73(3):2450-9.

27.

Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.

Lazzeri M, Mora M, Mulder LC, Marsicano G, Marinucci G, Boschi M, Bruzzone P, Alfani D, Cortesini R, Rossini M.

J Urol. 1998 Apr;159(4):1364-9.

PMID:
9507885
28.

Human CD46 aberrant splicing in transgenic mice.

Mulder LC, Rossini M, Mora M.

Gene. 1997 Feb 20;186(1):83-6.

PMID:
9047349
29.

Do macrophages kill through apoptosis?

Aliprantis AO, Diez-Roux G, Mulder LC, Zychlinsky A, Lang RA.

Immunol Today. 1996 Dec;17(12):573-6. Review.

PMID:
8991289
30.

Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.

Mulder LC, Mora M, Lazzeri M, Boschi M, Ciccopiedi E, Melli C, Bruzzone P, Alfani D.

Transplant Proc. 1996 Apr;28(2):589. No abstract available.

PMID:
8623287
31.

Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.

Mulder LC, Mora M, Lazzeri M, Boschi M, Ciccopiedi E, Marinucci G, Melli CM, Bruzzone P, Alfani D, Cortesini R, Rossini M.

Transplant Proc. 1996 Feb;28(1):127-9. No abstract available.

PMID:
8644143
32.

Mice transgenic for human CD46 and CD55 are protected from human complement attack.

Mulder LC, Mora M, Ciccopiedi E, Melli C, Nuti S, Marinucci G, Bruzzone P, Lazzeri M, Lorenzini R, Alfani D, et al.

Transplant Proc. 1995 Feb;27(1):333-5. No abstract available.

PMID:
7533403
33.

Preimplantation embryo sexing by polymerase chain reaction amplification of the sry gene on single mouse blastomeres.

Mulder LC, Sacco MG, Mangiarini L, Brown J, Collotta A, Villa A, De Giovanni AM, Vezzoni P, Clerici L.

Genet Anal Tech Appl. 1993;10(6):147-9.

PMID:
8043307

Supplemental Content

Loading ...
Support Center